In March 2022, the SIGMA Consortium and VAC4EU formally joined forces and expressed their shared vision and mutual goal to continue collaborating, developing existing synergies, and sharing expertise and knowledge, information, and tools developed by the two networks for pharmacoepidemiology/real world evidence studies and activities.
